OBParp 150mg Tablet

OBParp 150mg Tablet is a PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitor belonging to the class of cancer medications. It contains the active ingredient Olaparib and is used to treat pancreatic and prostate cancer. This medication may be given alone or in combination with other anticancer medications.

Do not take olaparib if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing.

Your healthcare provider will conduct blood tests before starting treatment and every month during treatment, as this medicine may reduce the counts of red blood cells, white blood cells, and platelets. Inform your healthcare provider before starting treatment if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.

This medication is not advised during pregnancy since it may harm the fetus and cause miscarriage. For women of reproductive age, a pregnancy test is recommended before beginning this medication. It is preferable to continue using birth control for at least six months after treatment is finished.

Do not breastfeed while receiving treatment, as it is unknown whether OBParp 150mg Tablet passes into breast milk. Men should not donate sperm for at least 3 months after treatment is finished.

Inform your doctor about all medicines you are taking, including prescription medicines, over-the-counter drugs, vitamins, and supplements.

Treatment of Prostate cancer Metastatic Pancreatic cancer

OBParp 150mg Tablet works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Olparib 150mg Tablet prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.

The medicine will be prescribed to you by a healthcare professional in a hospital setting. OBParp 150mg Tablet is available as a tablet to be taken with or without food, as directed by your healthcare provider. Your healthcare professional will decide the dose based on your conditions. Avoid crushing, opening, or dissolving the tablet and swallow it whole with a glass of water. Take the OBParp 150mg Tablet at the same time every day.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common Shortness of breath Nausea Vomiting Fatigue Dyspepsia Loss of appetite Dizziness Diarrhoea Headache Serious Neutropenia Acute myeloid leukemia Leukopenia Thrombocytopenia Lung problems

OBParp 150mg Tablet can lower blood cell counts, thus it's best to get blood tests done at regular intervals. When undergoing this therapy, stay out of direct sunlight and wear sunscreen with an SPF of at least 50 before going outside. OBParp 150mg Tablet should not be stopped without first talking to your doctor. When using this medication, stay away from grapefruit juice as it may raise your blood levels of the drug. It is recommended to inform your doctor about other anticancer drugs you have been taking. It's critical to maintain a sufficient fluid intake because dehydration can exacerbate symptoms such as diarrhea and other gastrointestinal disorders. Even if you feel better or see a change in your symptoms, you should still talk to your doctor before stopping OBParp 150mg Tablet. Remember to attend all scheduled appointments and follow-up visits with your healthcare provider to ensure your treatment is effective and any side effects are managed appropriately. With proper monitoring and management, Obrenza 100mg Tablet can be an effective treatment option for certain types of cancer.